Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival. - sprookjes - yvandenbroek - TriplyDB

Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.

Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.

http://www.wikidata.org/entity/Q35920356

about

HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30.PLK1 down-regulates parainfluenza virus 5 gene expression Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from molecular pathogenesis to targeted therapy in leukemia and solid tumors.Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma.The 14th International Conference on Human Retrovirology: HTLV and related retroviruses (July 1-4, 2009; Salvador, Brazil)Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis Human T-lymphotropic virus proteins and post-translational modification pathways Henipavirus V protein association with Polo-like kinase reveals functional overlap with STAT1 binding and interferon evasion.HTLV-I p30: a versatile protein modulating virus replication and pathogenesis.

P2860

Q24307735-2B60E9D7-B4FA-4E98-8895-43BA493A58F9 Q26852683-7620675F-7123-47EB-9BCA-05D04670A54F Q26864846-2F47FC09-35F0-4D98-96AF-A0CDD4C56E13 Q33482061-E51F0E24-5EEF-4B46-9B1A-ED125F5D6F6D Q33486509-3BEF6927-1B15-4F76-8884-B5CF83A5DC71 Q34310872-2FF877FA-79A5-453D-AEE3-B5CFBDBA7F22 Q34606461-4B20D1A2-14F0-4CB7-AF04-4A0FEFD7AA35 Q34869625-1DEE0210-257E-4953-B982-A8D05E53CAA3 Q35071356-3C94825C-8B10-4D33-A580-DFA169846132 Q35138140-13DE9A04-ADF3-46F7-AA12-5EFDDBF38E54 Q35261245-A455C22E-17EF-480B-AD3E-915FCECC4A8C Q35261449-3771B941-2FFD-4517-A2CF-8A7DA732FADC Q35261463-940D3C15-91DA-4E8C-BCC0-4B41AC57EF21 Q36299426-152945E5-5348-430C-8537-B346873860B0 Q36434903-D77EB273-2EE7-49EE-842F-A419650078F8 Q37016512-21B94E26-07E7-47EE-86E8-42925E1CBA65 Q37325424-E1169BFC-36B8-46F5-A928-CDAC654EE317 Q38068180-9BFE2ABE-4477-41A7-A11B-4A94A0798045 Q38156859-9A9DBB67-BC6C-491E-99F1-F2AC39B0EC25 Q39766832-E5614189-33F8-4A1E-BC21-C015288BFD07 Q41811371-77FB6625-2437-44F8-BF76-E3EE295E2C9E

P2860

Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.

http://www.wikidata.org/entity/Q35920356

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@ast

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@en

type

label

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@ast

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@en

prefLabel

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@ast

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@en

P1433

Q35920356-17A75459-2FB4-49FB-9434-4EF47FB4A71B

P1476

Q35920356-6B486B44-023F-41CE-BDA1-481A3BFC0013

P2093

Q35920356-124897E0-FBC8-4A89-B970-5A925F918EB6

Q35920356-7E4C1813-78EC-41A2-85E7-550BAFBC4AAC

Q35920356-831D4276-E3D3-4E4C-A973-484E97CE3AC5

Q35920356-87C05CE4-9DB0-435F-961E-996F91FFB1E0

Q35920356-D578B64D-902B-4A2E-9796-C89905B1F8A5

Q35920356-EC77E9B9-07C5-4A54-A5EE-CB689C0A97E9

P2860

Q35920356-00FDC9A0-2519-4407-9F36-3A9F4A78CD6C

Q35920356-036989A0-5FDE-412F-89E0-4912F515DF8D

Q35920356-0762DC14-6013-4D47-BCD7-42D89FC6FF69

Q35920356-0DA7960F-5E5D-49D9-9E9A-2372A148F325

Q35920356-1800B8CE-AE33-4EC0-B455-92978AD1C603

Q35920356-18B6EB2E-CA7E-45C8-A944-80FE10405413

Q35920356-1BF1C939-F4F4-441B-BD2A-E3024AF02940

Q35920356-1D5CC2EA-258F-4145-8EFB-0F3BF712C2BE

Q35920356-1FCDBE46-11C6-4886-BCAE-04576A047059

Q35920356-2485C084-6BB4-46FC-9586-307C3D260191

P2888

Q35920356-85F64EBE-2C19-46E6-B0AA-170D5E28C6FA

P304

Q35920356-D2A65ED7-843D-4DAA-8D01-6F15B3C56CF6

P31

Q35920356-41431339-B322-4296-8D94-D5B60A954014

P356

Q35920356-A4B340BB-5A2E-4DA9-AA89-5C4EE7ABEFB3

P478

Q35920356-696D1750-F10B-43FF-B7FD-154A875D12ED

P577

Q35920356-EA1D62B0-55B2-4502-88BA-42B47012C99F

P5875

Q35920356-4AC1AB01-D639-4CA5-9AD8-1D23D635F57B

P6179

Q35920356-A595542B-8029-49D1-898C-0F52349CACED

P698

Q35920356-1A495AC3-1B9A-4C4A-9F56-FAA915AAB2CC

P921

Q35920356-6F1640BB-270C-480B-8CC1-FE644DF5C62C

P932

Q35920356-104BBB27-3742-4573-B834-C02687292D87

P356

P1433

P1476

Human T-lymphotropic virus typ ...... ytes to enhance cell survival.

@en

P2093

Andrew J Phipps

http://www.w3.org/2001/XMLSchema#string

Antara Datta

http://www.w3.org/2001/XMLSchema#string

Hajime Hiraragi

http://www.w3.org/2001/XMLSchema#string

Lee Ratner

http://www.w3.org/2001/XMLSchema#string

Lee Silverman

http://www.w3.org/2001/XMLSchema#string

Michael D Lairmore

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

Plk1 promotes nuclear translocation of human Cdc25C during prophase

HTLV-1 p30II: selective repressor of gene expression

Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes

Cdc25 protein phosphatases in cell proliferation

HIV-1 viral protein R (Vpr) & host cellular responses

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions

From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner?

P2888

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-4-49

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6204530

http://www.w3.org/2001/XMLSchema#string

P6179

1013257788

http://www.w3.org/2001/XMLSchema#string

P698

17634129

http://www.w3.org/2001/XMLSchema#string

P921

Human T-lymphotropic virus 1

P932

1937004

http://www.w3.org/2001/XMLSchema#string